Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Power Shares德銀石油基金
DBO
5
兩倍做多彭博原油ETF-ProShares
UCO
暫無數據
快訊 | Insulet Corporation:伯恩斯坦將目標價從$200下調至$175
Canaccord Genuity維持對Insulet的買入評級,將目標價下調至$179
Canaccord Genuity分析師William Plovanic維持對Insulet(納斯達克:PODD)的買入評級,並將目標價從$249下調至$179。
Leerink Partners將Insulet的評級下調至市場表現,目標價下調至$145
Leerink Partners分析師Mike Kratky將Insulet(納斯達克:PODD)的評級從跑贏大市下調至與大市持平,並將目標價從$247下調至$145。
Insulet Is Maintained at Hold by TD Cowen
儘管存在增長重置風險,RBC表示Insulet的估值仍具吸引力
Insulet(PODD)在服務2型糖尿病患者方面面臨執行挑戰,貼片式胰島素泵領域即將迎來競爭,且其長期增長前景存在不確定性,這些因素均使其股價需要重新調整,儘管該股票的
Insulet Is Maintained at Outperform by Bernstein